masthead-news

News & Events

Categories

Reset Categories

Filter by Topics

AACR AMP ASCO Biomarker Discovery Bristol-Myers Squibb CDx Centre Leon Berard Clinical Biomarker CMDCAS Conference Conference Call Daiichi Sankyo Durviz ESHG FFPE Financial Results Forums Gamidor Genomeweb HTG HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBLCL Cell of Origin Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq System HTGEdgeSeq IAP IHC Illumina Immuno-Oncology ISO 13485 IVD Merck KGaA Molecular Profiling Nasdaq Nature Research Custom Media Webcast Nature.com NGS NSCLC Patents Platform comparison PMWC Presentation QIAGEN Reports RNA-Seq Sequencing Symposium Thermo Fisher Transcriptome VERI/O Laboratory Services Webinar WIN Consortium WIN Symposium
Reset Filter Reset All

HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

TUCSON, Ariz., Nov. 02, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 17, 2016 in New York City.

full press release

Posted on:

Return To List

Page last updated December 19, 2017